Sampre Nutritions Limited (BOM:530617)
India · Delayed Price · Currency is INR 22.38
-1.91 (-7.86%)
At close: Feb 12, 2026
Sampre Nutritions Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
| 359.76 | 251.24 | 251.47 | 371.07 | 231.26 | 182.33 | |
Revenue Growth (YoY) | 62.62% | -0.09% | -32.23% | 60.46% | 26.83% | -26.64% |
Cost of Revenue | 281.76 | 229.77 | 166.1 | 287.81 | 167.33 | 119.64 |
Gross Profit | 78 | 21.48 | 85.37 | 83.25 | 63.92 | 62.7 |
Selling, General & Admin | 35.21 | 30.36 | 28.78 | 23.95 | 19.07 | 17.83 |
Other Operating Expenses | 62.56 | 29.75 | 15.34 | 18.75 | 9.67 | 10.55 |
Operating Expenses | 119.45 | 79.81 | 62.45 | 60.92 | 45.08 | 46.46 |
Operating Income | -41.44 | -58.34 | 22.92 | 22.34 | 18.84 | 16.23 |
Interest Expense | -10.66 | -16.98 | -19.04 | -17.77 | -17.16 | -15.3 |
Interest & Investment Income | 2.81 | 2.81 | 0.37 | 0.02 | 0.04 | 0.01 |
Other Non Operating Income (Expenses) | -2.74 | -2.74 | -0.08 | -0.41 | 2.23 | 0.18 |
EBT Excluding Unusual Items | -52.04 | -75.25 | 4.17 | 4.18 | 3.95 | 1.11 |
Gain (Loss) on Sale of Assets | - | - | - | - | -0.23 | -0.03 |
Other Unusual Items | - | - | 0.7 | - | - | - |
Pretax Income | -52.04 | -75.25 | 4.87 | 4.18 | 3.72 | 1.09 |
Income Tax Expense | 4.19 | 1.47 | 2.56 | 0.7 | 0.64 | 0.33 |
Net Income | -56.23 | -76.72 | 2.32 | 3.47 | 3.08 | 0.76 |
Net Income to Common | -56.23 | -76.72 | 2.32 | 3.47 | 3.08 | 0.76 |
Net Income Growth | - | - | -33.33% | 12.86% | 306.61% | -77.45% |
Shares Outstanding (Basic) | 115 | 57 | 27 | 23 | 19 | 19 |
Shares Outstanding (Diluted) | 115 | 57 | 27 | 38 | 19 | 19 |
Shares Change (YoY) | 92.30% | 105.80% | -26.83% | 94.80% | - | - |
EPS (Basic) | -0.49 | -1.36 | 0.08 | 0.15 | 0.16 | 0.04 |
EPS (Diluted) | -0.49 | -1.36 | 0.08 | 0.09 | 0.16 | 0.04 |
EPS Growth | - | - | -8.89% | -42.06% | 306.61% | -77.45% |
Free Cash Flow | - | -1.93 | 2.44 | -35.27 | 11.07 | -25.32 |
Free Cash Flow Per Share | - | -0.03 | 0.09 | -0.94 | 0.57 | -1.31 |
Gross Margin | 21.68% | 8.55% | 33.95% | 22.44% | 27.64% | 34.38% |
Operating Margin | -11.52% | -23.22% | 9.11% | 6.02% | 8.15% | 8.90% |
Profit Margin | -15.63% | -30.54% | 0.92% | 0.94% | 1.33% | 0.41% |
Free Cash Flow Margin | - | -0.77% | 0.97% | -9.51% | 4.79% | -13.89% |
EBITDA | -20.71 | -38.63 | 41.25 | 40.55 | 35.18 | 34.31 |
EBITDA Margin | -5.76% | -15.38% | 16.40% | 10.93% | 15.21% | 18.82% |
D&A For EBITDA | 20.73 | 19.7 | 18.33 | 18.22 | 16.34 | 18.08 |
EBIT | -41.44 | -58.34 | 22.92 | 22.34 | 18.84 | 16.23 |
EBIT Margin | -11.52% | -23.22% | 9.11% | 6.02% | 8.15% | 8.90% |
Effective Tax Rate | - | - | 52.48% | 16.83% | 17.30% | 30.29% |
Revenue as Reported | 363.51 | 254.99 | 252.65 | 371.79 | 234.03 | 182.65 |
Advertising Expenses | - | 0.43 | 0.35 | 0.57 | 0.2 | 0.44 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.